메뉴 건너뛰기




Volumn 50, Issue 5, 2005, Pages 879-881

Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DICLOFENAC;

EID: 18844441496     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2658-x     Document Type: Note
Times cited : (5)

References (18)
  • 1
    • 0038386052 scopus 로고    scopus 로고
    • Diclofenac reduces the indicence of acute pancreatitis after endoscopic retrograde cholangiopancreatography
    • Murray B, Carter R, Imrie C, et al.: Diclofenac reduces the indicence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 124:1786-1791, 2003
    • (2003) Gastroenterology , vol.124 , pp. 1786-1791
    • Murray, B.1    Carter, R.2    Imrie, C.3
  • 3
    • 19244370051 scopus 로고    scopus 로고
    • Major early complications from diagnostic and therapeutic ERCP: A prospective multicenter study
    • Loperfido S, Angelini G, Benedetti G, et al.: Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48:1-10, 1998
    • (1998) Gastrointest Endosc , vol.48 , pp. 1-10
    • Loperfido, S.1    Angelini, G.2    Benedetti, G.3
  • 4
    • 0035120260 scopus 로고    scopus 로고
    • Complications of diagnostic and therapeutic ERCP: A prospective multicenter study
    • Masci E, Toti G, Mariani A, et al.: Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96:417-423, 2001
    • (2001) Am J Gastroenterol , vol.96 , pp. 417-423
    • Masci, E.1    Toti, G.2    Mariani, A.3
  • 5
    • 0035491041 scopus 로고    scopus 로고
    • Risk factors for post-ERCP pancreatitis: A prospective multicenter study
    • Freeman ML, DiSario JA, Nelson DB, et al.: Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Gastrointest Endosc 54:425-434, 2001
    • (2001) Gastrointest Endosc , vol.54 , pp. 425-434
    • Freeman, M.L.1    DiSario, J.A.2    Nelson, D.B.3
  • 6
    • 0036901010 scopus 로고    scopus 로고
    • Complications of endoscopic sphincterotomy: Results from a single tertiary referral center
    • Barthet M, Lesavre N, Desjeux A, et al.: Complications of endoscopic sphincterotomy: results from a single tertiary referral center. Endoscopy 34:991-997, 2002
    • (2002) Endoscopy , vol.34 , pp. 991-997
    • Barthet, M.1    Lesavre, N.2    Desjeux, A.3
  • 7
    • 0033978197 scopus 로고    scopus 로고
    • Pharmacologic treatment can prevent pancreatic injury after ERCP: A meta-analysis
    • Andriulli A, Leandro G, Niro G, et al.: Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 51:1-7, 2000
    • (2000) Gastrointest Endosc , vol.51 , pp. 1-7
    • Andriulli, A.1    Leandro, G.2    Niro, G.3
  • 8
    • 18344404181 scopus 로고    scopus 로고
    • Gabexate or somatostatin administration before ERCP in patients at high-risk for post-ERCP pancreatitis: A multicenter placebo-controlled randomized clinical trial
    • Andriulli A. Clemente R, Teruzzi V, et al.: Gabexate or somatostatin administration before ERCP in patients at high-risk for post-ERCP pancreatitis: a multicenter placebo-controlled randomized clinical trial. Gastrointest Endosc 56:488-195, 2002
    • (2002) Gastrointest Endosc , vol.56 , pp. 488-1195
    • Andriulli, A.1    Clemente, R.2    Teruzzi, V.3
  • 9
    • 0026612320 scopus 로고
    • Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?
    • Binmoeller KF, Harris AG, Dumas R, et al.: Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut 33:1129-1133, 1992
    • (1992) Gut , vol.33 , pp. 1129-1133
    • Binmoeller, K.F.1    Harris, A.G.2    Dumas, R.3
  • 10
    • 0028605566 scopus 로고
    • The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy
    • Arcidiacono R, Gambitta P, Rossi A, et al.: The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy 26:715-718, 1994
    • (1994) Endoscopy , vol.26 , pp. 715-718
    • Arcidiacono, R.1    Gambitta, P.2    Rossi, A.3
  • 11
    • 0035128505 scopus 로고    scopus 로고
    • Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography
    • Deviere J, Le Moine O, van Laethem JL, et al.: Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 120:498-505, 2001
    • (2001) Gastroenterology , vol.120 , pp. 498-505
    • Deviere, J.1    Le Moine, O.2    Van Laethem, J.L.3
  • 12
    • 0035676599 scopus 로고    scopus 로고
    • Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis
    • Sudhindran S, Bromwich E, Edwards PR: Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 88:1178-1182, 2001
    • (2001) Br J Surg , vol.88 , pp. 1178-1182
    • Sudhindran, S.1    Bromwich, E.2    Edwards, P.R.3
  • 13
    • 0037280967 scopus 로고    scopus 로고
    • Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial
    • Moreto M, Zaballa M, Casado I, et al.: Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc 57:1-7, 2003
    • (2003) Gastrointest Endosc , vol.57 , pp. 1-7
    • Moreto, M.1    Zaballa, M.2    Casado, I.3
  • 14
    • 0034938522 scopus 로고    scopus 로고
    • A randomized double blind study of interleukin-10 for prevention of ERCP-induced pancreatitis
    • Dumot JA, Conwell DL, Zuccaro G, et al.: A randomized double blind study of interleukin-10 for prevention of ERCP-induced pancreatitis. Am J Gastroenterol 96:2098-2102, 2001
    • (2001) Am J Gastroenterol , vol.96 , pp. 2098-2102
    • Dumot, J.A.1    Conwell, D.L.2    Zuccaro, G.3
  • 15
    • 0013163856 scopus 로고    scopus 로고
    • Complications of endoscopic sphincterotomy: Can heparin prevent acute pancreatitis after ERCP?
    • Rabenstein T, Roggenbuck S, Framke B, et al.: Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc 55:476-483, 2002
    • (2002) Gastrointest Endosc , vol.55 , pp. 476-483
    • Rabenstein, T.1    Roggenbuck, S.2    Framke, B.3
  • 16
    • 0031729824 scopus 로고    scopus 로고
    • Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction
    • Tarnasky PR, Palesch YK, Cunningham JT, et al.: Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 115:1518-1524, 1998
    • (1998) Gastroenterology , vol.115 , pp. 1518-1524
    • Tarnasky, P.R.1    Palesch, Y.K.2    Cunningham, J.T.3
  • 17
    • 0037344269 scopus 로고    scopus 로고
    • Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study
    • Fazel A, Quadri A, Catalano MF, et al.: Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 57:291-294, 2003
    • (2003) Gastrointest Endosc , vol.57 , pp. 291-294
    • Fazel, A.1    Quadri, A.2    Catalano, M.F.3
  • 18
    • 0038281401 scopus 로고    scopus 로고
    • Prevention of post-ERCP pancreatitis: Pharmacologic solution or patient selection and pancreatic stents?
    • editorial
    • Freeman ML: Prevention of post-ERCP pancreatitis: pharmacologic solution or patient selection and pancreatic stents? Gastroenterology 124:1977-1980, 2003 [editorial]
    • (2003) Gastroenterology , vol.124 , pp. 1977-1980
    • Freeman, M.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.